ERBB2/HOXB13 co-amplification with interstitial deletion of BRCA1 defines a unique subset of breast cancers
Irene Rin Mitsiades, Maristela Lika Onozato, Anthony John Iafrate, Daniel F. Hicks, Dennis C. Sgroi, Esther Rheinbay
The paper identifies ERBB2/HOXB13 co-amplification with BRCA1 loss as a unique subset of breast cancers associated with shorter progression-free survival.
bioRxiv · Aug 4, 2024 · PreprintGenomics